Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
4.230
+0.070 (1.68%)
May 27, 2026, 2:24 PM EDT - Market open

Perspective Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jun '22 Jun '21
Net Income
-111.13-103.12-79.28-46.51-7.27-3.39
Depreciation & Amortization
3.653.252.310.990.290.19
Stock-Based Compensation
9.428.975.393.741.090.39
Other Adjustments
-2.286.7421.481.950.020.05
Change in Receivables
-0.060.111.050.20.410.03
Changes in Inventories
--0.010.36-2.67-0.27
Changes in Accounts Payable
-2.360.151.891.570.240.08
Changes in Accrued Expenses
0.962.013.61.120.140.16
Changes in Unearned Revenue
--1.428---
Changes in Other Operating Activities
-0.110.81-2.74-0.330.05-0.06
Operating Cash Flow
-92.37-82.48-18.29-36.91-7.71-2.84
Capital Expenditures
-14.95-12.75-54.41-1.07-0.27-0.38
Sale of Property, Plant & Equipment
--0.34--0
Purchases of Intangible Assets
-0.13-0.14-0.07-0.02-0.02-0.03
Purchases of Investments
-247.57-119.84-243.51---
Proceeds from Sale of Investments
199.89173.9578.7322.76--
Payments for Business Acquisitions
---2.7--
Investing Cash Flow
-62.7641.23-218.9324.37-0.28-0.41
Long-Term Debt Repaid
-0.05-0.05-0.05-0.07--
Net Long-Term Debt Issued (Repaid)
-0.05-0.05-0.05-0.07--
Issuance of Common Stock
164.7510.36289.430.920.0664.69
Net Common Stock Issued (Repurchased)
164.7510.36289.430.920.0664.69
Preferred Share Dividends Paid
------0.01
Other Financing Activities
----0.07--
Financing Cash Flow
164.710.31289.390.790.0664.68
Net Cash Flow
9.57-30.9552.16-11.76-7.9461.44
Free Cash Flow
-107.32-95.23-72.71-37.99-7.98-3.22
FCF Margin
-17365.90%-10773.00%-5000.55%-2648.88%--32.01%
Free Cash Flow Per Share
-1.31-1.29-1.13-1.42-0.56-0.94
Levered Free Cash Flow
-124-111.1-100.67-43.94-9.5-7.07
Unlevered Free Cash Flow
-132.82-120.62-109.89-36.1-8.65-3.74
Updated May 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q